cyclosporine and Marchiafava-Micheli Syndrome

cyclosporine has been researched along with Marchiafava-Micheli Syndrome in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (28.21)	18.2507
2000's	12 (30.77)	29.6817
2010's	15 (38.46)	24.3611
2020's	1 (2.56)	2.80

Authors

Authors	Studies
Matsukawa, T; Miyagishima, T; Nagai, J; Oshimi, K; Suto, K	1
Chen, XJ; Chen, YM; Guo, Y; Liu, TF; Liu, XM; Wang, SC; Yang, WY; Zhang, L; Zhu, XF; Zou, Y	1
Babushok, DV; Duke, JL; Huang, Y; Monos, DS; Olson, TS; Oved, JH; Stanley, N; Teachey, DT	1
Arranto, C; Baldomero, H; Gerull, S; Halter, JP; Heim, D; Kleber, M; Medinger, M; Passweg, JR; Soltermann, Y	1
Barrett, J; Childs, RW; Cook, L; Donohue, T; Geller, N; Khuu, H; Kurlander, R; Leitman, S; Pantin, J; Ramos, C; Shah, AA; Stroncek, D; Tian, X; Young, NS	1
Afanasyev, B; Babenko, E; Bondarenko, S; Golubovskaya, I; Ivanova, M; Kozlov, V; Kruchkova, I; Kulagin, A; Lisukov, I; Pronkina, N; Sipol, A; Stancheva, N; Vavilov, V	1
Kulasekararaj, AG; Marsh, JC	1
Asano, J; Shinzato, I; Takafuta, T; Tanaka, Y; Ueda, R	1
Crescenzio, N; Decimi, V; Doria, A; Dufour, C; Foglia, L; Longoni, D; Marra, N; Martire, B; Pagliano, S; Palumbo, G; Pillon, M; Ramenghi, U; Ruggiero, A; Saracco, P; Svahn, J; Timeus, F; Vallero, S	1
Chang, W; Chen, F; Fu, C; Jin, Z; Ma, X; Miao, M; Qiu, H; Ruan, C; Sun, A; Tang, X; Wu, D; Xue, S	1
Almeida, AM; Muus, P; Schrezenmeier, H; Urbano-Ispizua, Á; Ware, RE; Wilson, A	1
Marte, M; Nunez, O; Scheinberg, P; Young, NS	1
Risitano, AM	2
Akahane, D; Asano, N; Ichikawa, N; Kobayashi, H; Sato, K; Shimizu, I; Sumi, M; Ueki, T; Ueno, M; Watanabe, M	1
Bauters, T; Benoit, Y; Bordon, V; Dhooge, C; Robays, H	1
Fischer, S; Ganser, A; Gohrbandt, B; Knobloch, K; Leyh, RG; Schubert, J; Tiede, A; Zardo, P	1
Frickhofen, N; Heimpel, H; Kaltwasser, JP; Schrezenmeier, H	1
Chuhjo, T	1
Barraco, F; Bianchi, P; Boschetti, C; Fermo, E; Vercellati, C; Zanella, A	1
Ansari-Lari, A; Brodsky, RA; Veidt, RG	1
Chuhjo, T; Feng, X; Kimura, A; Kondo, Y; Mizoguchi, H; Mochizuki, K; Nakao, S; Omine, M; Sugimori, C; Takami, A; Teramura, M; Yamazaki, H	1
Denisova, V; Gilevich, A; Kozhevnikov, V; Kozlov, V; Kruchkova, I; Kulagin, A; Lisukov, I; Pronkina, N; Sizikova, S	1
Schmidt, RE; Scholz, C; Schubert, J	1
Kimball, J; Rosenfeld, SJ; Vining, D; Young, NS	1
de Wolf, JT; Halie, MR; Smit, JW; van Imhoff, GW; van Kamp, H; Vellenga, E	1
Brodsky, RA; Medof, ME; Nagarajan, S; Young, NS	1
Arnoulet, C; Camerlo, J; Cappiello, MA; Gastaut, JA; Maraninchi, D; Sainty, D; Stoppa, AM; Vey, N	1
Fujisao, S; Horikawa, K; Iwamoto, N; Kawaguchi, T; Nagakura, S; Nakakuma, H; Nishimura, Y; Takatsuki, K	1
Ganser, A; Geissler, RG; Schmidt, RE; Scholz, C; Schubert, J	1
Ishikawa, S; Kai, T; Maruyama, Y; Noji, H; Saitoh, Y; Shichishima, T	1
Alcocer, M; Briz, M; Cabrera, R; Fernández, MN; Forés, R; Lago, C; Sanjuán, I	1
Arcese, W; Bacigalupo, A; Di Bona, E; Locasciulli, A; Locatelli, F	1
Chuhjo, T; Mizoguchi, H; Nakao, S; Shiobara, S; Teramura, M; Wang, H; Yamazaki, H	1
Kanai, S; Kanda, Y; Makimoto, A; Mineishi, S; Miyawaki, S; Nakai, K; Niiya, H; Ohnishi, M; Ohnishi, T; Saito, A; Saito, T; Suenaga, K; Takaue, Y; Takeuchi, T; Tanosaki, R; Tobinai, K	1
Asano, Y; Gondo, H; Maeda, M; Niho, Y; Okamura, S; Okamura, T; Osaki, K; Shimoda, K; Uchida, N; Yokoyama, T	1
Bittencourt, E; Gluckman, E; Leymarie, V; Noguera, ME; Sigaux, F; Socié, G	1
Matusda, T; Nakao, S; Shiobara, S; Takamatsu, H; Yamaguchi, M	1
Abdelhay, E; Bouzas, LF; de Souza, MH; Diamond, HR; Ribeiro, RC; Silva, ML; Tabak, DG; Valente, AN	1

Reviews

3 review(s) available for cyclosporine and Marchiafava-Micheli Syndrome

Article	Year
Management of the refractory aplastic anemia patient: what are the options? Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013 Topics: Adult; Age Factors; Alemtuzumab; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Benzoates; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Hydrazines; Immunosuppression Therapy; Immunosuppressive Agents; Middle Aged; Pyrazoles; Siblings; Survival Rate; Unrelated Donors	2013
Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going. British journal of haematology, 2011, Volume: 152, Issue:2 Topics: Adult; Algorithms; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Hemoglobinuria, Paroxysmal; History, 20th Century; Humans; Immunosuppression Therapy; Immunosuppressive Agents	2011
Immunosuppressive therapies in the management of acquired immune-mediated marrow failures. Current opinion in hematology, 2012, Volume: 19, Issue:1 Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Hemoglobinuria, Paroxysmal; Horses; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Rabbits	2012

Trials

7 trial(s) available for cyclosporine and Marchiafava-Micheli Syndrome

Article	Year
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes. American journal of hematology, 2013, Volume: 88, Issue:10 Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Risk Factors; Salvage Therapy; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult	2013
Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia. Blood, 2003, Feb-15, Volume: 101, Issue:4 Topics: Anemia, Aplastic; Antilymphocyte Serum; Blood Cell Count; Cyclosporine; Disease-Free Survival; Drug Therapy, Combination; Follow-Up Studies; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Kinetics; Leukemia; Methylprednisolone; Myelodysplastic Syndromes; Neoplasms; Recurrence; Remission Induction; Salvage Therapy; Survival Rate	2003
Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglobinuria. American journal of hematology, 2004, Volume: 77, Issue:1 Topics: Adolescent; Adult; Antilymphocyte Serum; Cyclosporine; DNA Mutational Analysis; Drug Monitoring; Erythropoietin; Female; Follow-Up Studies; Hemoglobins; Hemoglobinuria, Paroxysmal; Humans; Immunosuppression Therapy; Male; Membrane Proteins; Middle Aged; Mutation; Polymerase Chain Reaction; Recombinant Proteins; Thrombosis; Treatment Outcome	2004
Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood, 1995, Jun-01, Volume: 85, Issue:11 Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease-Free Survival; Female; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Myeloid, Acute; Life Tables; Male; Middle Aged; Prognosis; Salvage Therapy; Survival Rate; T-Lymphocytes; Treatment Outcome	1995
The effect of cyclosporine on haematological parameters in patients with paroxysmal nocturnal haemoglobinuria. British journal of haematology, 1995, Volume: 89, Issue:1 Topics: Adult; Aged; Anemia, Aplastic; Antigens, CD; Blood Cell Count; Cyclosporine; Female; Glycosylphosphatidylinositols; Hemoglobins; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Male; Neutrophils; Syndrome	1995
Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet (London, England), 2001, Jan-06, Volume: 357, Issue:9249 Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Infant; Leukemia; Male; Middle Aged; Mouth Neoplasms; Myelodysplastic Syndromes; Neoplasms; Risk Factors; Survival Analysis; Treatment Outcome	2001
Immunosuppressive therapy for patients with refractory anemia. Annals of hematology, 2001, Volume: 80, Issue:11 Topics: Adult; Aged; Anemia, Refractory; Antilymphocyte Serum; Cyclosporine; Female; Hemoglobinuria, Paroxysmal; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Immunosuppressive Agents; Leukocyte Count; Male; Middle Aged; Neutrophils; Treatment Outcome	2001

Other Studies

29 other study(ies) available for cyclosporine and Marchiafava-Micheli Syndrome

Article	Year
[Aplastic anemia following drug-induced liver injury]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2019, Volume: 60, Issue:7 Topics: Adolescent; Anemia, Aplastic; Antilymphocyte Serum; Chemical and Drug Induced Liver Injury; Cyclosporine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male	2019
[The Outcome of Severe Aplastic Anemia Children Treated with Reduced Dose of Cyclophosphamide Combined Cyclosporine A]. Zhongguo shi yan xue ye xue za zhi, 2020, Volume: 28, Issue:1 Topics: Anemia, Aplastic; Antilymphocyte Serum; Child; Cyclophosphamide; Cyclosporine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Treatment Outcome	2020
Development of hemolytic paroxysmal nocturnal hemoglobinuria without graft loss following hematopoietic stem cell transplantation for acquired aplastic anemia. Pediatric transplantation, 2019, Volume: 23, Issue:4 Topics: Adolescent; Anemia, Aplastic; Bone Marrow Cells; Chimerism; Cyclosporine; Diabetes Mellitus, Type 1; Graft Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Male; Membrane Proteins; Mutation; Neutrophils; Recurrence; Thrombocytopenia; Thrombosis; Treatment Outcome	2019
Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study. Annals of hematology, 2019, Volume: 98, Issue:6 Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclophosphamide; Cyclosporine; Drug Evaluation; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Retrospective Studies; T-Lymphocytes; Tissue Donors	2019
Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study. British journal of haematology, 2014, Volume: 164, Issue:4 Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Female; Flow Cytometry; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Infant; Male; Middle Aged; Prognosis; Prospective Studies; Survival Analysis; Young Adult	2014
Effects of immunosuppressive therapy in a patient with aplastic anemia-paroxysmal nocturnal hemoglobinuria (AA-PNH) syndrome during ongoing eculizumab treatment. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:2 Topics: Aged; Anemia, Aplastic; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Bacteremia; Blood Transfusion; Combined Modality Therapy; Complement Inactivating Agents; Cyclosporine; Escherichia coli Infections; Female; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Lenograstim; Recombinant Proteins; Shock, Septic; T-Lymphocytes; Urinary Tract Infections	2014
Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentre study. PloS one, 2014, Volume: 9, Issue:7 Topics: Adolescent; Anemia, Aplastic; Child; Child, Preschool; Cyclosporine; Glycosylphosphatidylinositols; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Longitudinal Studies; Treatment Outcome	2014
[Outcomes of allogeneic hematopoietic stem cell transplantation for 18 patients with paroxysmal nocturnal haemoglobinuria]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2015, Volume: 36, Issue:12 Topics: Anemia, Aplastic; Antilymphocyte Serum; Busulfan; Cyclophosphamide; Cyclosporine; Disease-Free Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Methotrexate; Mycophenolic Acid; Retrospective Studies; Siblings; Tacrolimus; Transplantation Conditioning; Treatment Outcome; Unrelated Donors; Vidarabine	2015
Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients. Haematologica, 2017, Volume: 102, Issue:3 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antilymphocyte Serum; Cerebrovascular Disorders; Child; Child, Preschool; Cyclosporine; Erythrocyte Transfusion; Female; Hemoglobinuria, Paroxysmal; Hemolysis; Heparin; Humans; Infant; Infant, Newborn; L-Lactate Dehydrogenase; Male; Middle Aged; Myocardial Infarction; Neutropenia; Neutrophils; Registries; Retrospective Studies; Thromboembolism; Warfarin	2017
Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine. Haematologica, 2010, Volume: 95, Issue:7 Topics: Adult; Anemia, Aplastic; Animals; Antilymphocyte Serum; Clone Cells; Cyclosporine; Drug Therapy, Combination; Female; Hemoglobinuria, Paroxysmal; Horses; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Retrospective Studies; Young Adult	2010
Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2011, Volume: 52, Issue:11 Topics: Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Hemoglobinuria, Paroxysmal; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Multiple Organ Failure	2011
Successful use of eculizumab in a pediatric patient treated for paroxysmal nocturnal hemoglobinuria. Journal of pediatric hematology/oncology, 2012, Volume: 34, Issue:8 Topics: Adrenal Cortex Hormones; Anemia, Aplastic; Anemia, Hemolytic; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Child; Combined Modality Therapy; Cyclosporine; Erythrocyte Transfusion; Female; Folic Acid; Hematopoietic Cell Growth Factors; Hemoglobinuria, Paroxysmal; Humans; Immunophenotyping; Immunosuppressive Agents; T-Lymphocytes	2012
Cardiac surgery in a patient with paroxysmal nocturnal hemoglobinuria. Haematologica, 2002, Volume: 87, Issue:8 Topics: Aged; Anemia, Aplastic; Anemia, Hemolytic; Aortic Valve Insufficiency; Cardiopulmonary Bypass; Complement Activation; Coronary Stenosis; Cyclosporine; Granulocyte Colony-Stimulating Factor; Heart Valve Prosthesis Implantation; Hemoglobinuria, Paroxysmal; Humans; Hypertension; Immunosuppressive Agents; Internal Mammary-Coronary Artery Anastomosis; Kidney Failure, Chronic; Male; Postoperative Complications; Preoperative Care; Risk; Thrombophilia; Thrombosis	2002
[Immunosuppressive therapy for low-risk MDS: markers for good response]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:4 Topics: Anemia, Refractory; Cyclosporine; Granulocytes; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Myelodysplastic Syndromes	2004
Severe aplastic anemia associated with paroxysmal nocturnal hemoglobinuria and lymphoplasmacytic lymphoma. Leukemia & lymphoma, 2005, Volume: 46, Issue:8 Topics: Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Neoplasms; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Fatal Outcome; Hemoglobinuria, Paroxysmal; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Time Factors; Waldenstrom Macroglobulinemia	2005
Roles of DRB1 1501 and DRB1 1502 in the pathogenesis of aplastic anemia. Experimental hematology, 2007, Volume: 35, Issue:1 Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anemia, Aplastic; Antilymphocyte Serum; Blood Cells; Child; Cyclosporine; Drug Therapy, Combination; Female; Hemoglobinuria, Paroxysmal; HLA-DR Antigens; HLA-DR Serological Subtypes; HLA-DRB1 Chains; Humans; Male; Middle Aged; Treatment Outcome	2007
Severe pancytopenia associated with a minor paroxysmal nocturnal haemoglobinuria clone and response to ciclosporin A in a heavily pretreated multiple myeloma patient. British journal of haematology, 2008, Volume: 141, Issue:1 Topics: Cyclosporine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Myeloma; Pancytopenia	2008
[Experimental therapy of hypoplastic paroxysmal nocturnal hemoglobinuria]. Immunitat und Infektion, 1995, Volume: 23, Issue:2 Topics: Adult; Antigens, CD; Antigens, CD34; CD59 Antigens; Cyclosporine; Female; Glycosylphosphatidylinositols; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Membrane Glycoproteins; Thrombocytopenia	1995
Genetic defects underlying paroxysmal nocturnal hemoglobinuria that arises out of aplastic anemia. Blood, 1995, Dec-15, Volume: 86, Issue:12 Topics: Anemia, Aplastic; Antilymphocyte Serum; Base Sequence; Cyclosporine; DNA Mutational Analysis; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Membrane Proteins; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; RNA Splicing; RNA, Messenger; Sequence Deletion; T-Lymphocytes	1995
Correction of aplastic anaemia complicating paroxysmal nocturnal haemoglobinuria: absence of eradication of the PNH clone and dependence of response on cyclosporin A administration. British journal of haematology, 1996, Volume: 93, Issue:1 Topics: Adult; Anemia, Aplastic; Cyclosporine; Female; Hemoglobinuria, Paroxysmal; Humans; Immunosuppression Therapy; Male; Time Factors	1996
Cyclosporin-responsive pancytopenia and HLA class II alleles of a patient with paroxysmal nocturnal hemoglobinuria. International journal of hematology, 1996, Volume: 63, Issue:2 Topics: Adult; Alleles; Cyclosporine; Hemoglobinuria, Paroxysmal; Histocompatibility Antigens Class II; Humans; Immunosuppressive Agents; Male; Pancytopenia	1996
G-CSF and cyclosporin induce an increase of normal cells in hypoplastic paroxysmal nocturnal hemoglobinuria. Annals of hematology, 1997, Volume: 74, Issue:5 Topics: Adult; Blood Cell Count; Cyclosporine; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Pancytopenia	1997
[Effective treatment combining antithymocyte globulin, cyclosporin A, and granulocyte colony-stimulating factor for atypical paroxysmal nocturnal hemoglobinuria accompanied by bone marrow hypoplasia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:3 Topics: Adult; Antilymphocyte Serum; Bone Marrow Diseases; Cyclosporine; Drug Therapy, Combination; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Treatment Outcome	1999
[Detection of PNH clones using flow cytometry in aplastic anemia and paroxysmal nocturnal hemoglobinuria]. Sangre, 1999, Volume: 44, Issue:3 Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; CD55 Antigens; CD59 Antigens; Clone Cells; Cyclosporine; Female; Flow Cytometry; Granulocytes; Hemoglobinuria; Hemoglobinuria, Paroxysmal; Hemolysis; Humans; Immunosuppressive Agents; Male; Middle Aged; T-Lymphocytes	1999
Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: the high prevalence at diagnosis. European journal of haematology, 2001, Volume: 66, Issue:3 Topics: Adult; Aged; Anemia, Aplastic; Antigens, CD; Antilymphocyte Serum; Cell Differentiation; Cyclosporine; Diagnosis, Differential; Female; Glycosylphosphatidylinositols; Granulocytes; Hemoglobinuria, Paroxysmal; Humans; Immunophenotyping; Immunosuppressive Agents; Leukocyte Count; Male; Middle Aged; T-Lymphocytes	2001
Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria. Experimental hematology, 2001, Volume: 29, Issue:5 Topics: Antilymphocyte Serum; Busulfan; Cladribine; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; Humans; Immunosuppressive Agents; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous	2001
Aplastic anemia and paroxysmal nocturnal hemoglobinuria: a follow-up study of the glycosylphosphatidylinositol-anchored proteins defect. The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4 Topics: Adult; Anemia, Aplastic; Antilymphocyte Serum; Blood Cell Count; Bone Marrow Transplantation; Clone Cells; Combined Modality Therapy; Cyclosporine; Female; Flow Cytometry; Follow-Up Studies; Glycosylphosphatidylinositols; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Immunotherapy; Male; Membrane Proteins; Middle Aged; Pregnancy; Pregnancy Complications, Hematologic; Prospective Studies; T-Lymphocytes; Transplantation, Homologous	2000
Expansion of a paroxysmal nocturnal hemoglobinuria (PNH) clone after cyclosporine therapy for aplastic anemia/PNH syndrome. Blood, 1992, Dec-01, Volume: 80, Issue:11 Topics: Adult; Anemia, Aplastic; Bone Marrow; Clone Cells; Cyclosporine; DNA; Female; Granulocytes; Hemoglobinuria, Paroxysmal; Humans; Karyotyping; Leukocytes; Syndrome	1992
Late marrow allograft rejection following alpha-interferon therapy for hepatitis in a patient with paroxysmal nocturnal hemoglobinuria. Bone marrow transplantation, 1992, Volume: 9, Issue:6 Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Graft Rejection; Hemoglobinuria, Paroxysmal; Hepatitis, Chronic; Humans; Interferon-alpha	1992